| mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.024 |
0.9 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |